Menu Search
Equities

CEL-SCI Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CVM:ASQ

CEL-SCI Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.80
  • Today's Change0.055 / 1.47%
  • Shares traded28.75k
  • 1 Year change-61.76%
  • Beta0.9298
Data delayed at least 15 minutes, as of Mar 05 2026 18:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2025, CEL-SCI Corp increased its cash reserves by 131.17%, or 6.22m. Cash Flow from Financing totalled 23.37m or -- of revenues. In addition the company used 17.12m for operations while cash used for investing totalled 38.11k.
Cash flow per share-3.62
Price/Cash flow per share--
Book value per share1.32
Tangible book value per share1.31
More ▼

Balance sheet in USDView more

CEL-SCI Corp has a Debt to Total Capital ratio of 39.96%, a lower figure than the previous year's 65.54%.
Current ratio1.39
Quick ratio1.35
Total debt/total equity0.6655
Total debt/total capital0.3996
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.